Vonoprazan (TAK-438 free base), a proton pump inhibitor (PPI), is a potent and orally active potassium-competitive acid blocker (P-CAB), with antisecretory activity. Vonoprazan inhibits H+,K+-ATPase activity in porcine gastric microsomes with an IC50 of 19 nM at pH 6.5. Vonoprazan is developed for the research of acid-related diseases, such as gastroesophageal reflux disease and peptic ulcer disease. Vonoprazan can be used for eradication of Helicobacter pylori[1][2][3].
Molecular Weight:
345.40
Purity:
99.89
CAS Number:
[881681-00-1]
Formula:
C17H16FN3O2S
Target:
Bacterial,Proton Pump
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
